CN106822629A - 茯苓玉米须口服液 - Google Patents
茯苓玉米须口服液 Download PDFInfo
- Publication number
- CN106822629A CN106822629A CN201611177138.4A CN201611177138A CN106822629A CN 106822629 A CN106822629 A CN 106822629A CN 201611177138 A CN201611177138 A CN 201611177138A CN 106822629 A CN106822629 A CN 106822629A
- Authority
- CN
- China
- Prior art keywords
- parts
- poria cocos
- peppermint
- corn stigma
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 42
- 244000197580 Poria cocos Species 0.000 title claims abstract description 27
- 235000008599 Poria cocos Nutrition 0.000 title claims abstract description 27
- 240000008042 Zea mays Species 0.000 title claims abstract description 26
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 title claims abstract description 25
- 235000002017 Zea mays subsp mays Nutrition 0.000 title claims abstract description 25
- 235000005822 corn Nutrition 0.000 title claims abstract description 25
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 19
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 19
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 19
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 19
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims abstract description 17
- 235000019477 peppermint oil Nutrition 0.000 claims abstract description 17
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 12
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 12
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 12
- 240000000249 Morus alba Species 0.000 claims abstract description 12
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 12
- 235000020224 almond Nutrition 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000002893 slag Substances 0.000 claims abstract description 6
- 238000000926 separation method Methods 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 241000723353 Chrysanthemum Species 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000005267 amalgamation Methods 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 241001251949 Xanthium sibiricum Species 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 238000010791 quenching Methods 0.000 abstract description 2
- 230000035922 thirst Effects 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 2
- 235000012054 meals Nutrition 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000001256 steam distillation Methods 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
茯苓玉米须口服液,包括以下质量份的原料:茯苓:20~40份、玉米须:20~40份、扁桃仁:8~12份、甘草:5~8份、桑叶:3~5份、菊花:3~5份、栀子花:3~5份、薄荷:6~10份,其制备时,先将薄荷进行薄荷油提取,并融入无水乙醇中静置,同时将茯苓切块并与提取过薄荷油的薄荷渣、玉米须、甘草、桑叶一同加入容器中进行一次煎液,然后将扁桃仁粉碎,然后与菊花、栀子花一同加入滤渣中进行二次煎液,合并两次煎液,然后直接将萃有薄荷油的无水乙醇加入合并煎液后并减压浓缩后得到成品。本发明可有效提高人体免疫力、促进物质代谢,并具有活血、益气、止渴等功效。
Description
技术领域
本发明涉及口服中药制剂领域,具体涉及一种健脾、润燥的茯苓玉米须口服液。
背景技术
茯苓,别名云苓、茯灵、松茯苓、松薯等,是寄生在松树根部的多孔菌科植物,是一种珍贵的药食两用菌,自古以来就是药食同源的保健食品,一直受到人们的关注,富含茯苓多糖等多种功效成分,具有健脾胃、利水消肿、降血脂、调节机体免疫、抗衰老、抗肿瘤、抗突变等功能;古人称茯苓为“四时神药”,因为它功效非常广泛,不分四季,将它与各种药物配伍,不管寒、温、风、湿诸疾,都能发挥其独特功效。
玉米须为禾本科玉蜀黍属植物玉米的花柱和花头,其营养价值颇高,是《中华人民共和国药典》1985版(一部)收录的常用药材品种之一,其富含多糖类、黄酮类、皂苷类、脂肪油、谷甾醇、生物碱、VK、苹果酸、氨基酸等多种代谢所必须的营养物质,味甘、淡,性平,可用于治疗肾炎、胆结石和糖尿病等,在治疗利尿消肿,清肝利胆,治肾炎水肿,脚气,黄疸肝炎,高血压等病症时有独特功效。
甘草,含有多种化学成分,主要成分有甘草酸、甘草甙等大量的研究表明,甘草甜素和黄酮类物质是甘草中最重要的生理活性物质,主要存在于甘草根表皮以内的部分。气微,味甜而特殊,有补脾益气,止咳祛痰,清热解毒,通经脉,利血气,具有调和诸药的功能。
目前,对于上述组分的药物的应用主要是以简单的散剂为主,需要经过人体机体的消化后方能被吸收,使得其这些制剂生物利用率相对较低,使用不方便,起效慢,而若采用传统水提法制备口服液制剂,其提取率仅为25%~32%,根本达不到工业生产的需要,造成了物料的严重浪费。
发明内容
本发明所解决的技术问题在于提供一种茯苓玉米须口服液,以解决上述技术背景中的缺陷。
本发明所解决的技术问题采用以下技术方案来实现:
茯苓玉米须口服液,包括以下质量份的原料:
茯苓:20~40份、玉米须:20~40份、扁桃仁:8~12份、甘草:5~8份、桑叶:3~5份、菊花:3~5份、栀子花:3~5份、薄荷:6~10份。
其优选质量份为:茯苓:25份、玉米须:25份、扁桃仁:10份、甘草:6份、桑叶:4份、菊花:4份、栀子花:4份、薄荷7份。
其具体制备方法如下:
1)按上述质量份取薄荷提取薄荷油,将提取的薄荷油按每100g薄荷5~8ml的比例溶于无水乙醇中,然后,在70~85℃条件下静置1.5~2h备用。
2)将茯苓切成8~10mm见方的小块,与提取过薄荷油的薄荷渣、玉米须、甘草、桑叶一同加入容器中,同时按每5g药物总质量加入50~60ml的比例加水,大火煮沸后转小火煎煮2~3h,进行固液分离,然后将扁桃仁用粉体磨磨碎,过80~100目筛,与菊花、栀子花一同加入滤渣中,同时往滤渣中按每5g药物总质量加入30~50ml的比例加水,大火煮沸后转小火煎煮1~2h,进行固液分离后合并两次的煎液,过滤。
3)将步骤1)与步骤2)中的液体合并,减压浓缩使药液在20℃下的相对密度为1.05~1.12,即得成品。
作为上述步骤的进一步改进:
所述薄荷油采用水蒸气蒸馏法提取。
所述步骤3)中合并液在进行减压浓缩之前,可添加苯甲酸钠作为防腐剂进行使用。
对步骤3)所得的成品须在高压灭菌后才能进行灌装。
有益效果:本发明茯苓玉米须口服液,通过在茯苓中添加玉米须进行调和补充,配合甘草以及多种清热药物中的多种有效物质可有效提高人体免疫力、促进物质代谢,具有抗疲劳、抗衰老等作用,同时还具有活血、益气、止渴和利尿消肿,清肝利胆,治肾炎水肿的功效。
具体实施方式
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体实施例,进一步阐述本发明。
实施例一:
在该实施例中包括以下组分的原料:
茯苓:230g、玉米须:300g、扁桃仁:120g、甘草:60g、桑叶:30g、菊花:50g、栀子花:50g、薄荷:80g。
制备时先将薄荷用水蒸气蒸馏法提取薄荷油,然后将提取的薄荷油加入到4ml的无水乙醇中,在75℃条件下静置100min备用;然后将茯苓切成8~10mm见方的小块,与提取过薄荷油的薄荷渣、玉米须、甘草、桑叶一同加入容器中,与8000ml的水一并加入容器中,对容器进行大火加热,煮沸后转小火煎煮130min,然后进行第一次固液分离,再将扁桃仁用粉体磨磨碎,过80目筛,然后与菊花和栀子花以及固液分离后的残渣加6800ml水,大火煮沸后转小火煎煮120min,然后进行第二次固液分离,合并两次固液分离的液体,过滤掉液体中的杂质。
然后将此无水乙醇静置后的溶液加入到过滤掉杂质的上述合并液中,搅拌均匀后减压浓缩使药液在20℃下的相对密度为1.08,然后高压灭菌后灌装即可。
实施例二:
在该实施例中包括以下组分的原料:
茯苓:250g、玉米须:250g、扁桃仁:100g、甘草:60g、桑叶:40g、菊花:40g、栀子花:40g、薄荷70g。
制备时先将薄荷用水蒸气蒸馏法提取薄荷油,然后将提取的薄荷油加入到3.5ml的无水乙醇中在80℃条件下静置120min备用;然后将茯苓切成8~10mm见方的小块,与提取过薄荷油的薄荷渣、玉米须、甘草、桑叶一同加入容器中,与7800ml的水一并加入容器中,对容器进行大火加热,煮沸后转小火煎煮150min,然后进行第一次固液分离,再将扁桃仁用粉体磨磨碎,过80目筛,然后与菊花和栀子花以及固液分离后的残渣加7000ml水,大火煮沸后转小火煎煮100min,然后进行第二次固液分离,合并两次固液分离的液体,过滤掉液体中的杂质。
然后将此无水乙醇静置后的溶液加入到过滤掉杂质的上述合并液中,一并添加苯甲酸钠作为防腐剂,搅拌均匀后再减压浓缩使药液在20℃下的相对密度为1.10,然后高压灭菌后灌装即可。
以上显示和描述了本发明的基本原理、主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (5)
1.茯苓玉米须口服液,其特征在于,包括以下质量份的原料:茯苓:20~40份、玉米须:20~40份、扁桃仁:8~12份、甘草:5~8份、桑叶:3~5份、菊花:3~5份、栀子花:3~5份、薄荷:6~10份。
2.根据权利要求1所述的茯苓玉米须口服液,其特征在于,包括以下质量份的原料:茯苓:25份、玉米须:25份、扁桃仁:10份、甘草:6份、桑叶:4份、菊花:4份、栀子花:4份、薄荷7份。
3.一种茯苓玉米须口服液的制备方法,其特征在于,采用权利要求1或2中所述的各组分的原料制备茯苓玉米须口服液,其具体制备方法如下:
1)按上述质量份取薄荷提取薄荷油,将提取的薄荷油按每100g薄荷5~8ml的比例溶于无水乙醇中,然后,在70~85℃条件下静置1.5~2h备用;
2)将茯苓切成8~10mm见方的小块,与提取过薄荷油的薄荷渣、玉米须、甘草、桑叶一同加入容器中,同时按每5g药物总质量加入50~60ml的比例加水,大火煮沸后转小火煎煮2~3h,进行固液分离,然后将扁桃仁用粉体磨磨碎,过80~100目筛,与菊花、栀子花一同加入滤渣中,同时往滤渣中按每5g药物总质量加入30~50ml的比例加水,大火煮沸后转小火煎煮1~2h,进行固液分离后合并两次的煎液,过滤;
3)将步骤1)与步骤2)中的液体合并,减压浓缩使药液在20℃下的相对密度为1.05~1.12,即得成品。
4.根据权利要求3所述的制备方法,其特征在于,所述步骤1)中的薄荷油采用水蒸气蒸馏法提取。
5.根据权利要求3所述的制备方法,其特征在于,所述步骤3)中合并液在进行减压浓缩之前添加苯甲酸钠作为防腐剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611177138.4A CN106822629A (zh) | 2016-12-19 | 2016-12-19 | 茯苓玉米须口服液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611177138.4A CN106822629A (zh) | 2016-12-19 | 2016-12-19 | 茯苓玉米须口服液 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106822629A true CN106822629A (zh) | 2017-06-13 |
Family
ID=59139577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611177138.4A Withdrawn CN106822629A (zh) | 2016-12-19 | 2016-12-19 | 茯苓玉米须口服液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106822629A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190110207A (ko) * | 2018-03-20 | 2019-09-30 | 재단법인 경북바이오산업연구원 | 옥미수 추출물의 에틸아세테이트 분획물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 |
-
2016
- 2016-12-19 CN CN201611177138.4A patent/CN106822629A/zh not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190110207A (ko) * | 2018-03-20 | 2019-09-30 | 재단법인 경북바이오산업연구원 | 옥미수 추출물의 에틸아세테이트 분획물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 |
KR102037530B1 (ko) | 2018-03-20 | 2019-10-29 | 재단법인 경북바이오산업연구원 | 옥미수 추출물의 에틸아세테이트 분획물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103923790A (zh) | 一种和血补气药酒 | |
CN102396611A (zh) | 一种养肝、护肝保健茶 | |
CN103005553A (zh) | 一种增强免疫力中草药复合饮料的制备方法 | |
CN103981060A (zh) | 金银花保健酒及其制备方法 | |
CN101554242B (zh) | 金银花饮及其加工工艺 | |
CN105167106A (zh) | 一种具有延缓衰老功效的玫瑰花保健饮料 | |
CN102994309B (zh) | 银杏高粱酒及银杏高粱健身酒 | |
CN105495218A (zh) | 一种醒酒保健饮品及其制备方法 | |
CN107998240A (zh) | 一种提神醒脑缓解疲劳清咽保健含片的配方及其制备方法 | |
CN103404640A (zh) | 一种扶肝养胃茶及其制备方法 | |
CN103893389A (zh) | 一种降血压的中药茶饮 | |
CN106109521A (zh) | 一种三七口服液 | |
CN106822629A (zh) | 茯苓玉米须口服液 | |
CN106106840A (zh) | 一种滋阴美容芝麻油的制备方法 | |
CN107125514A (zh) | 一种健身型植物凉茶饮料及其制备方法 | |
CN106266026A (zh) | 一种解酒保肝的姜黄素组合物 | |
CN106728373A (zh) | 茯苓灵芝蜂蜜口服液 | |
CN106387215A (zh) | 一种葛根蛹虫草茶及其制备方法 | |
CN112168944A (zh) | 预防新冠肺炎的中药组合物、提取物、其制备方法及应用 | |
CN111670985A (zh) | 一种含水溶性大麻二酚保健茶的制备方法 | |
CN106309601A (zh) | 含中草药的解酒保健饮品及制备方法 | |
CN104721508A (zh) | 一种治疗上呼吸道感染的药物组合物及制备方法 | |
CN104371892A (zh) | 首乌乌发中药酒及制备方法 | |
CN104222400A (zh) | 醒酒护肝、宁心安神的普洱茶膏及其加工方法 | |
CN106620017A (zh) | 茯苓竹荪口服液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170613 |